Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia

Exclusion Criteria

• •Major coronary or cerebrovascular event in the 3 months prior to inclusion.
• •Serious intercurrent illnesses, such as acute infections, outbreaks of autoimmune or inflammatory pathology, active cancer, or other pathologies that, at the investigator's discretion, could interfere with the conduct of the study.
• •Major surgery during the 2 months prior to inclusion.
• •Pharmacological treatment maintained during the 3 months prior to inclusion with NSAIDs, corticosteroids or chemotherapy.
• •Toxic habits, including severe smoking, alcohol or drug abuse, which in the opinion of the investigator could interfere with the conduct of the study.
• •Pregnancy or puerperium.
• •Any other condition that limits compliance with the visits or procedures established in the protocol.